脑部放疗，上午比下午敏感许多！
( t1 N+ z3 ?5 g$ f j4 M7 @1 W5 ~
: f, N9 w) l1 x2 s/ Z q# r( p0 W/ C0 S' c8 k& Y& o4 h
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
$ ~% I4 V r" ]/ G0 a- lGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
$ i, R8 E; l8 C& J/ p( IRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
; f; @, ?) x* h; r) [5 ]6 m( LSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
2 `! g5 z+ o2 |' ?' m: y6 Q4 j7 f
6 K# y: p5 i9 Z! Y3 o% MAbstract$ z, Q) X% s+ J8 s+ R, h$ [. r# F! [
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
1 B2 o4 \' k, J" \
* _' e7 n* e+ H+ k" hMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic., r1 s0 n N; r
5 q' C/ \+ K* p! Q6 V9 Y! ZRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
C* `: R* t/ t) _8 s% u# E4 ]# {
0 p5 N6 \4 s. i6 @! WCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
, L! N2 X- e/ R6 M& @* @! @' ?3 |! z
|
显身卡
